Quantum biochemistry description of PI3Kα enzyme bound to selective inhibitors
Francisca Joseli Freitas de Sousa1, Francisca Fernanda Nunes Azevedo1, Francisco Lucas Santos de Oliveira2
1Department of Biochemistry and Molecular Biology, Federal University of Ceará, Fortaleza, Brazil.
Abstract:
The PI3K class I is composed of four PI3K isoforms that serve as regulatory enzymes governing cellular metabolism, proliferation, and survival. The hyperactivation of PI3Kα is observed in various types of cancer and is linked to poor prognosis. Unfortunately, the development inhibitors selectively targeting one of the isoforms remains challenging, with only few agents in clinical use. The main difficulty arises from the high conservation among residues at the ATP-binding pocket across isoforms, which also serves as target pocket for inhibitors. In this work, molecular dynamics and quantum calculations were performed to investigate the molecular features guiding the binding of selective inhibitors, alpelisib and GDC-0326, into the ATP-binding pocket of PI3Kα. While molecular dynamics allowed crystallographic coordinates to relax, the interaction eergy between each amino acid residues and inhibitors was obtained by combining the Molecular Fractionation with Conjugated Caps scheme with Density Functional Theory calculations. In addition, the atomic charge of ligands in the bound and unbound (free) was calculated. Results indicated that the most relevant residues for the binding of alpelisib are Ile932, Glu859, Val851, Val850, Tyr836, Met922, Ile800, and Ile848, while the most important residues for the binding of GDC-0326 are Ile848, Ile800, Ile932, Gln859, Glu849, and Met922. In addition, residues Trp780, Ile800, Tyr836, Ile848, Gln859 Val850, Val851, Ile932 and Met922 are common hotspots for both inhibitors. Overall, the results from this work contribute to improving the understanding of the molecular mechanisms controlling selectivity and highlight important interactions to be considered during the rational design of new agents.Communicated by Ramaswamy H. Sarma.
Insights
This study investigated how selective inhibitors bind to PI3Kα, a key cancer target. Understanding these molecular interactions aids in designing more effective cancer drugs by identifying crucial binding hotspots.
Area of Science:
- Biochemistry
- Molecular Biology
- Computational Chemistry
Background:
- Phosphoinositide 3-kinase (PI3K) class I enzymes regulate vital cellular processes.
- Hyperactivation of PI3Kα is implicated in various cancers, driving poor prognosis.
- Developing selective PI3K isoform inhibitors is challenging due to conserved ATP-binding pockets.
Purpose of the Study:
- To investigate the molecular features governing the binding of alpelisib and GDC-0326 to the PI3Kα ATP-binding pocket.
- To identify key amino acid residues and interactions critical for selective inhibitor binding.
- To provide insights for the rational design of novel PI3Kα-targeting agents.
Main Methods:
- Molecular dynamics simulations to relax protein structures.
- Quantum calculations using the Molecular Fractionation with Conjugated Caps scheme and Density Functional Theory (DFT).
- Calculation of atomic charges for ligands in bound and unbound states.
Main Results:
- Identified key residues for alpelisib binding: Ile932, Glu859, Val851, Val850, Tyr836, Met922, Ile800, and Ile848.
- Identified key residues for GDC-0326 binding: Ile848, Ile800, Ile932, Gln859, Glu849, and Met922.
- Highlighted common hotspot residues (Trp780, Ile800, Tyr836, Ile848, Gln859, Val850, Val851, Ile932, Met922) for both inhibitors.
Conclusions:
- The study elucidates molecular mechanisms underlying PI3Kα inhibitor selectivity.
- Identified critical interactions that can guide the rational design of new, selective PI3K inhibitors.
- Contributes to the development of more effective targeted cancer therapies.
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Enzyme Inhibition
IP3/DAG Signaling Pathway


